
--- Page 1 ---
icd.0-3 8500/3 PAtIent hIstOry: * DATE of LMP: Srh cod: breuot, N0s c50.9 DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: CA L BREAST .POST-OP DIAGNOSIS: SAME  OPERATIVE PROCEDURE: LEF"T MODIFIED RADICAL MASTECTOMY CLINICAL HISTORY: * MATERIAL SUBMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE Lt breast & axillary content FINAL DIAGNOSIS: FINAL DIAGNOSIS: BREAST AND. AXILLA, LESD, MODIFIED RADICAL MASTECTOMY:S INFILTRATING DUCIAL CARCINOMA S"A2-A7").4.5 BY 4.5 BX 3.5 C4, NOTTINGHAM 6/9 (TUBULES 3, NUCLEI 3. MITOSIS I) , WITH LYMPHOVASCULAR PERMRATION, INVOLVING THE DEEP DERMIS - DUCTAL CARCINOMA IN-SITU, SOLID TYPE, NUCLEAR GRADE 2, LESS THAN 1  MARGINS OF RESECTION ARE FREE OF TUSOR  NIPPLE FREE OF TUMOR TWO OF TWENTY-SIX (2/26) LEFT AXILLARY LYMPH NODES INVOLVED WITH TUMOR, LARGEST LYMPH NODE 2.3 CM ISS REPLACED BY TUMOR  NOTe: ER/PR immunoperoxidase assay and Her-2/Neu testing was porformed on block "A6". Cross refer ESTROGEN/PROGESTERONE AND HER-2/NEU REPORTS Using appropriate positive and negative controls, the test fox the presence of these hormone receptor. protains is performed by the immunoperoxidase method. and reported according to the. On adjuvant therapy for breast cancer, of consensus statement A positive ER or PR tumc. snows any nuclear. immunostaining, and is semiquantitated as indicated Result Semiquantitative Statement ER positive Percant cells staining as: (0- 0t 1+ 10t; 2+ 104; 3+ 80s) PR positive Percent cells staining as: (0- 0t; 1+ 04; 2+ 10t; 3+ 90t) *****++************************* HER-2/NEU - DAKO HERCEPTEST: A FAINT/BARELY PERCEPTIBLE MEMBRANE STAINING IS DETECTED IN MORE THAN 1O% OF THE TUDMOR CELLS. THE CELLS ARE ONLY STAINED IN PART OF THBIR MEMBRANE. _HER-2/NEU IS INTERPRETED AS NEGATIVE (SCORE 1+). NOTE: The Her-2/NeU and estrogen assays xere performad with FDA approved. xeceptor immunoperoxidase test used in this case has been developed and the performance characteristics. methods. The progesterone determined by the Departmant of Pathology at. They have not been cleared or approved by the U.s. Food and Drug Administration. UUID:60E8A9CF-3E2D-4E36-947D-448BA27C6561 TCGA-BH-A18N-01A-PR Redactedd